Description:
Formoterol + Budesonide Inhaler is a combination medication used in the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). It contains Formoterol, a long-acting bronchodilator, and Budesonide, an inhaled corticosteroid. Together, they help improve breathing, reduce airway inflammation, and prevent the recurrence of respiratory symptoms such as wheezing, breathlessness, and chest tightness.
Therapeutic Uses:
Long-term management of bronchial asthma
Maintenance therapy for COPD, including chronic bronchitis and emphysema
Prevention of asthma exacerbations and respiratory flare-ups
Mechanism of Action:
Formoterol is a long-acting beta-2 agonist (LABA) that works by relaxing the muscles surrounding the airways, resulting in bronchodilation and easier airflow.
Budesonide is an inhaled corticosteroid (ICS) that reduces inflammation, swelling, and mucus production in the airways, helping to prevent asthma attacks and COPD exacerbations.
Dosage Form:
Metered-Dose Inhaler (MDI) or Dry Powder Inhaler (DPI), depending on formulation
Prescription Status:
Prescription-only medication
Note:
This inhaler is intended for regular maintenance use, not for immediate relief of acute symptoms. Patients should follow proper inhalation technique and rinse the mouth after each use to reduce the risk of oral thrush. Always use under the supervision of a healthcare provider.
Would you like this description adapted for a marketing brochure, pharmacy listing, or export documentation?
